Spatiotemporal control of coacervate formation within liposomes
Siddharth Deshpande (TU Delft - BN/Cees Dekker Lab, Kavli institute of nanoscience Delft)
Frank Brandenburg (Student TU Delft, Kavli institute of nanoscience Delft)
Anson Lau (TU Delft - BN/Cees Dekker Lab, Kavli institute of nanoscience Delft)
Mart G.F. Last (Kavli institute of nanoscience Delft, Student TU Delft)
Willem Kasper Spoelstra (Student TU Delft, Kavli institute of nanoscience Delft)
Louis Reese (Kavli institute of nanoscience Delft, TU Delft - BN/Marileen Dogterom Lab)
Sreekar Wunnava
Marileen Dogterom (Kavli institute of nanoscience Delft, TU Delft - BN/Bionanoscience)
Cees Dekker (TU Delft - BN/Cees Dekker Lab, Kavli institute of nanoscience Delft)
More Info
expand_more
Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.
Abstract
Liquid-liquid phase separation (LLPS), especially coacervation, plays a crucial role in cell biology, as it forms numerous membraneless organelles in cells. Coacervates play an indispensable role in regulating intracellular biochemistry, and their dysfunction is associated with several diseases. Understanding of the LLPS dynamics would greatly benefit from controlled in vitro assays that mimic cells. Here, we use a microfluidics-based methodology to form coacervates inside cell-sized (~10 µm) liposomes, allowing control over the dynamics. Protein-pore-mediated permeation of small molecules into liposomes triggers LLPS passively or via active mechanisms like enzymatic polymerization of nucleic acids. We demonstrate sequestration of proteins (FtsZ) and supramolecular assemblies (lipid vesicles), as well as the possibility to host metabolic reactions (β-galactosidase activity) inside coacervates. This coacervate-in-liposome platform provides a versatile tool to understand intracellular phase behavior, and these hybrid systems will allow engineering complex pathways to reconstitute cellular functions and facilitate bottom-up creation of synthetic cells.